drugset / Trial / NCT03199807
Phase IB/II Study of NRT Combined With Radiotherapy for Advanced HCC
Phase 1/2
Unknown
40 enrolled
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
NaSingle-groupOpen-labelTreatment
Summary
The study herein successfully developed a new immunotherapeutic approach combined with radiotherapy, and tried to proved it to be more effective and safe.
Timeline
- Start
- 2017-07-20
- Primary completion
- 2020-07-20
- Completion
- 2021-07-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NRT | Cell therapy | 5e+09 cells | Intravenous |
| Subject | NRT | Cell therapy | 1e+10 cells | Intravenous |